Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials

Jennifer Le-Rademacher, Rahul Kanwar, Drew Seisler, Deirdre R. Pachman, Rui Qin, Alexej Abyzov, Kathryn J. Ruddy, Michaela S. Banck, Ellen M. Lavoie Smith, Susan G. Dorsey, Neil K. Aaronson, Jeff Sloan, Charles L. Loprinzi, Andreas S. Beutler

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences